We use cookies to operate this website and to improve its usability. Full details of what cookies are, why we use them and how you can manage them can be found by reading our Privacy & Cookies page. Please note that by using this site you are consenting to the use of cookies.

INTERPHEX Webinar Series

The Webinar Series aims to support INTERPHEX's robust conference program and will serve as the industry's year round education resource, covering the hottest topics and trends.

Upcoming Webinars

Taking Life Sciences to the Cloud

Date: June 12, 2014
Time: 2:00pm-3:00pm (-5 GMT)
Speakers: John Niziolek, Practice Leader, Compliance, Cornerstone OnDemand and Aaron Weinstein, Senior Director - Validation Services, IPS - Integrated Project Services

Presented by


Webinar Archive

Listen to recordings of past webinars from INTERPHEX's 2012-2013 Webinar Series. The Webinar Series aims to support INTERPHEX's robust conference program and will serve as the industry's year round education resource, covering the hottest topics and trends.

Going Beyond The Batch: Benefitting From Continuous Thermal Viral Inactivation & Sterilization

Date: February 13, 2014
Time: 3:00pm-4:00pm (-5 GMT)
Speaker: MicroThermics

When used for viral inactivation, sterilization, or pasteurization of liquid biologicals such as media, pharmaceuticals, and nutraceuticals, Continuous Flow Thermal (CFT) Processing offers many crucial advantages over traditional processing. These can include:

  • Lower Up-Fit Costs
  • Reduced Production Times and Cost
  • Higher And More Consistent Product Quality
  • The Ability To Develop New Products

Listen Now

Optimizing a Continuous Wet Granulation Process by Understanding Granule Properties

Date: Wednesday, March 5, 2014
Time: 2:00 PM - 3:00 PM EST
Speaker: GEA

In developing a continuous wet granulation process, it is easy to produce a large number of samples by varying both the formulation as well as the process parameters. Commonly used granule measurements include loss-on drying of residual moisture content, and particle size measurements from which correlations including the Carr Index and Hausner ration may be calculated. However, it is seen that these measurements are not sufficient to differentiate between a large number of samples produced at conditions which are not drastically different. Using a powder rheometer, we have been able to repeatably measure and produce reliable trends at multiple points in the process train (powder feeders, wet granules, dry granules) to determine which powder properties are critical-to-quality in generating the desired tablet properties. In this study two formulations were studied to demonstrate how to use improved understanding of granule properties to develop the design space of a continuous manufacturing process.

Listen Now

Emerging Market Capital Sourcing

Date: October 1, 2013
Time: 2:00pm-3:00pm (-5 GMT)
Speaker: Kevin Batche, Sr. Procurement Manager, IPS – Integrated Project Services

Evaluated from an operations standpoint rather than a technical standpoint, this webinar looks at common fears as they relate to sourcing process and packaging equipment from emerging markets. Of primary concern are the risks associated with material segregation, cross-contamination, test reports, qualification documentation, as well as parts and service after start-up.

  • Benefits/Risks of emerging market capital sourcing as it relates to the execution of NA capital projects
  • Learn how NA pharma owner initiatives and concerns have shaped the supplier qualification process
  • Learn how the qualification process should be executed, results evaluated and the risk factor determined

Listen Now

The Challenges and Opportunities in Converting an Existing Facility to a Hybrid or a Single Use Facility

Date: June 6, 2013
Time: 2:00pm-3:00pm EST (-5 GMT)
Speaker: Roman Rodriguez, Mobius Group Global Manager, EMD Millipore

Converting all or part of an existing facility to single use technologies can be dictated by a diverse yet intertwined set of parameters that are technical, strategic and administrative. Additional parameters will impact the decision including personnel, schedule, current facility design, existing equipment, product comparability, and inventory control management.

This presentation will assist with the decision making process by highlighting the key considerations for each of these parameters.

By participating in this webinar, you will:

  • Learn about the evolution of the Biotech market
  • Understand Single-use technologies
  • Review the opportunities and challenges around an Hybrid or Single-Use solution

Listen Now

FAST DoE by Means of Continuous Technologies

Date: Thursday, May 23, 2013
Andrew Birkmire, Process Development Manager, GEA Process Engineering Inc.
Kris Schoeters, Product Manager Continuous Processing, GEA Pharma Systems
RichardSteiner, Business Development Manager Continuous Processing, GEA Pharma Systems

Design of Experiments describes a set of controlled investigations that have been designed to evaluate process variations. Even a simple DoE is comprised of several trials, which can be time-consuming when working with the traditional batch systems.

This presentation describes a number of case studies which clearly show that using continuous technologies, the time of executing a DoE is significantly decreased.

The equipment used for the case studies is a ConsiGma™-1, the R&D version of the continuous wet granulation and drying system by GEA Pharma Systems.

The case studies described cover amongst others the influence of API properties on final product characteristics, tuning of release profiles by changing the ratio of the ingredients of a formulation, high drug load applications and melt granulation processes.

By means of these case studies, also other benefits of continuous technologies and the use of DoE will be highlighted, such as the possibility to establish a sound, scientifically-based Pat strategy that only measures those parameters that have an impact on the critical quality attributes.

  1. DOE to increase process knowledge and set up PAT strategy
  2. Continuous technologies decrease Time to market & Cost
  3. Continuous technologies & DOE provide increased end quality

Listen Now

Join Our Mailing List